Category Archives: OGN
Assessing the Impact of the Organon Spin-Off on Merck
Merck is progressing toward the spin-off of its subsidiary, Organon & Co., which is expected to be completed by the end of the June. Organon will include Merck’s women’s health products, biosimilars and certain established brands, most of which have … Continue reading
Posted in Health Care, MRK, OGN
Tagged Merck, Merck & Co., Organon, Organon & Co.
Comments Off on Assessing the Impact of the Organon Spin-Off on Merck
Merck Spin-Off of Organon Targeted for 21Q2
In recent weeks, Merck has been following through on its plan to spin-off its subsidiary, Organon & Co., to shareholders. On March 17, it filed its Form 10 registration statement related to the transaction. On March 24, it posted on … Continue reading
Posted in Health Care, MRK, OGN
Tagged Merck, Organon, Pharmaceuticals industry
Comments Off on Merck Spin-Off of Organon Targeted for 21Q2